Abbott offers EU concessions over $25 billion St. Jude deal
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
BRUSSELS (Reuters) - Medical device maker Abbott Laboratories (NYSE: ABT) has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc (NYSE: STJ), according to the European Commision.
The move pushed back the European Commission's decision on the deal to Nov. 21 from Nov. 9, according to a filing on the EU competition enforcer's website on Thursday. It did not provide details.
The Commission can either accept the offer, demand more or open an investigation which can take up to five months.
Abbott and St Jude last month announced the sale of some of their medical devices worth about $1.12 billion to Japanese company Terumo Corp <4543.T> as part of their deal.
The deal comes as medical equipment makers come under pressure to offer a wider range of products to hospital customers.
(Reporting by Foo Yun Chee; Editing by Alexandra Hudson)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fred's (FRED) Falls, Halted on WBA/RAD Antitrust Concerns
- New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients
- Tucows (TCX) to Acquire eNom from Rightside (NAME) for $83.5M
Create E-mail Alert Related CategoriesLitigation, Mergers and Acquisitions, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!